Apollo Hospitals Sees Sharp Open Interest Surge Amidst Weak Price Performance

1 hour ago
share
Share Via
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has witnessed a notable 12.13% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and subdued investor participation, suggests a complex interplay of directional bets and market positioning that investors should carefully analyse.
Apollo Hospitals Sees Sharp Open Interest Surge Amidst Weak Price Performance

Open Interest and Volume Dynamics

On 1 April 2026, Apollo Hospitals recorded an open interest (OI) of 26,338 contracts, up from 23,488 contracts the previous session, marking an absolute increase of 2,850 contracts or 12.13%. This rise in OI was accompanied by a trading volume of 19,578 contracts, indicating robust participation in the derivatives market. The futures segment alone accounted for a value of approximately ₹28,219.48 lakhs, while the options segment’s notional value stood at an extraordinary ₹15,522.29 crores, culminating in a total derivatives value of ₹31,419.62 lakhs.

Such a pronounced increase in open interest typically reflects fresh positions being established, either by new buyers or sellers. However, the context of price movement is crucial to interpret the directional bias behind these positions.

Price Performance and Market Sentiment

Despite the surge in derivatives activity, Apollo Hospitals’ stock price has been under pressure. The share price declined by 1.59% on the day, underperforming its hospital sector peers by 1.63%. Over the past three consecutive sessions, the stock has fallen by 3.52%, signalling sustained selling pressure. Intraday price swings were notable, with the stock touching a high of ₹7,587 (+2.26%) and a low of ₹7,250.50 (-2.27%), but the weighted average price skewed closer to the day’s low, indicating that the bulk of trading occurred near the lower price levels.

Further technical analysis reveals that Apollo Hospitals is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring a bearish trend. This technical backdrop, combined with falling delivery volumes (down 23.23% to 2.63 lakh shares on 30 March compared to the 5-day average), suggests waning investor conviction in the stock’s near-term upside.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Interpreting the Open Interest Surge: Directional Bets and Positioning

The simultaneous rise in open interest and decline in price often points to increased short selling or bearish positioning by market participants. Traders may be initiating fresh short positions, anticipating further downside in Apollo Hospitals’ shares. Alternatively, some long holders might be hedging their exposure through derivatives, contributing to the open interest build-up.

The futures value of ₹28,219.48 lakhs and the massive options notional value suggest that institutional players are actively managing risk and positioning themselves strategically. The underlying stock price of ₹7,326 further contextualises these derivatives levels, indicating that strike prices and futures contracts are clustered around this price point, which could act as a pivot for upcoming price action.

Moreover, the stock’s liquidity profile supports sizeable trades, with a 5-day average traded value allowing for trade sizes up to ₹8.87 crores without significant market impact. This liquidity is attractive for large institutional participants to establish or unwind positions efficiently.

Sector and Market Context

While Apollo Hospitals has underperformed its sector and the broader Sensex, which gained 1.54% on the same day, the hospital industry remains a critical defensive sector amid market volatility. However, the stock’s current Mojo Score of 52.0 and a revised Mojo Grade of Hold (downgraded from Buy on 9 January 2026) reflect tempered expectations. This rating adjustment signals that while the company maintains a large-cap status with a market capitalisation of ₹1,08,047 crores, investors should exercise caution given the recent technical and derivatives market signals.

Why settle for Apollo Hospitals Enterprise Ltd.? SwitchER evaluates this Hospital large-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Implications for Investors

Investors should interpret the rising open interest in Apollo Hospitals’ derivatives with caution. The increase in OI amid falling prices and declining delivery volumes suggests that bearish sentiment is gaining traction. Traders holding long positions may consider protective strategies such as options hedging or reducing exposure, while those inclined to short the stock might view the current technical setup as favourable.

However, the hospital sector’s defensive nature and Apollo’s large-cap status mean that any sharp declines could attract value buyers, potentially stabilising the stock. Monitoring the evolution of open interest alongside price and volume trends in the coming sessions will be critical to gauge whether the current derivatives activity translates into sustained directional moves.

In summary, the derivatives market signals a complex battle between bulls and bears, with fresh positions being established on both sides. Investors should remain vigilant, combining technical analysis with fundamental insights and sector trends to navigate the evolving landscape effectively.

Conclusion

Apollo Hospitals Enterprise Ltd.’s recent surge in open interest by over 12% in its derivatives segment, set against a backdrop of declining share prices and subdued investor participation, highlights a nuanced market positioning scenario. While the stock faces near-term headwinds reflected in its Hold rating and technical weakness, the active derivatives market suggests significant interest from institutional players in managing risk and positioning for future moves. Careful monitoring of these dynamics will be essential for investors seeking to capitalise on or protect against potential directional shifts in this large-cap hospital stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News